The long-term risk of neoplasia in Crohn's disease (CD) patients treated with infliximab is undefined. The aim was to assess, in a multicenter, matched-pair study, whether infliximab use in CD is associated with an increased frequency of neoplasia in the long term.
Biancone, L., Petruzziello, C., Orlando, A., Kohn, A., Ardizzone, S., Daperno, M., et al. (2011). Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair study. INFLAMMATORY BOWEL DISEASES, 17(3), 758-766 [10.1002/ibd.21416].
Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair study
BIANCONE, LIVIA;SICA, GIUSEPPE;CALABRESE, EMMA;PALLONE, FRANCESCO
2011-03-01
Abstract
The long-term risk of neoplasia in Crohn's disease (CD) patients treated with infliximab is undefined. The aim was to assess, in a multicenter, matched-pair study, whether infliximab use in CD is associated with an increased frequency of neoplasia in the long term.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Cancer in Crohn’s Disease Patients Treated with Infliximab.pdf
solo utenti autorizzati
Licenza:
Copyright dell'editore
Dimensione
162.92 kB
Formato
Adobe PDF
|
162.92 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
